Hauser curbs enthusiasm for Boston Scientific's lead-free implanted defibrillator

January 2, 2013 by MassDevice staff

Noted cardiologist and frequent medtech critic Dr. Robert Hauser warns that doctors need more data on the safety and effectiveness before widely accepting Boston Scientific's newly acquired and FDA approved lead-free implantable defibrillator.

Cameron Health's S-ICD

Frequent medtech challenger Dr. Robert Hauser offered some words of warning for physicians clamoring over Boston Scientific's (NYSE:BSX) wire-free implantable defibrillator: curb your enthusiasm.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.